Allergan competitors

Allergan Competitors include XOMA, Novartis, GlaxoSmithKline and Bristol-Myers Squibb.
Add company...
Allergan
Allergan is a global pharmaceutical company.
XOMA
XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Founding Date
Founding Date
1948
Founding Date
1981
Founding Date
1996
Founding Date
2000
Founding Date
1887
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Parsippany Troy Hills, US
Locations
Emeryville, US HQ
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
Brentford, GB HQ
Locations
New York, US HQ
Lawrence Township, US
Bi, DE
Zug, CH
Braine L'alleud, BE
Hopewell, US
Devens, US
see more
Employees
Employees
16,70046% decrease
Employees
1878% decrease
Employees
126,0004% increase
Employees
98,462
Employees
23,7005% decrease
Valuation ($)
Valuation ($)
64.8 b
Valuation ($)
134.4 m
Valuation ($)
175.5 b
Valuation ($)
101.9 b
Valuation ($)
94 b
Facebook likes
Facebook likes
219
Facebook likes
N/A
Facebook likes
304.3 k
Facebook likes
273 k
Facebook likes
120.2 k
Twitter followers
Twitter followers
23 k
Twitter followers
185
Twitter followers
234.4 k
Twitter followers
163.4 k
Twitter followers
120.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$52.7m (FY, 2017)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
£30.2b (FY, 2017)
Revenue (est.)
$19.4b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$17.2b (FY, 2017)
Cost of goods
£10.3b (FY, 2017)
Cost of goods
$4.9b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$31.9b (FY, 2017)
Gross profit
£19.8b (FY, 2017)
Gross profit
$14.5b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
$7.7b (FY, 2017)
Net income
£2.2b (FY, 2017)
Net income
$4.5b (FY, 2016)

Operating

Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
8 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
$ 15.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

XOMA
HQ
Emeryville, US
Employees
18

XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,700↓ 5% decrease

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company